|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
233,220,000 |
Market
Cap: |
57.00(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.21 - $0.61 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Computer Software |
Level
III Sector: |
Application Software |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Asensus Surgical is a medical device company. Co. is focused on the market development for and commercialization of the Senhance® Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance Surgical System is a multi-port laparoscopic platform designed to maintain laparoscopic MIS standards. The Senhance System is available in Europe, the U.S., Japan, Taiwan, Russia and select other countries. The Senhance System has a CE Mark in Europe for adult and pediatric laparoscopic abdominal and pelvic surgery, as well as limited thoracic surgeries excluding cardiac and vascular surgery.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
18,134 |
18,134 |
604,288 |
Total Buy Value |
$0 |
$5,078 |
$5,078 |
$420,192 |
Total People Bought |
0 |
1 |
1 |
2 |
Total Buy Transactions |
0 |
1 |
1 |
3 |
Total Shares Sold |
0 |
18,134 |
18,134 |
45,144 |
Total Sell Value |
$0 |
$5,078 |
$5,078 |
$15,882 |
Total People Sold |
0 |
1 |
1 |
1 |
Total Sell Transactions |
0 |
1 |
1 |
2 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Frost Phillip Md Et Al |
10% Owner |
|
2013-03-22 |
4 |
B |
$0.25 |
$500,000 |
I/I |
2,000,000 |
13,122,346 |
1.5 |
- |
|
Spragens Jeffrey G |
President and CEO |
|
2013-03-22 |
4 |
B |
$0.25 |
$100,000 |
D/D |
400,000 |
2,545,285 |
3.23 |
- |
|
Hsiao Jane Ph D |
Chairman of the Board |
|
2012-10-25 |
4 |
OE |
$0.25 |
$196,346 |
I/I |
785,383 |
785,383 |
|
- |
|
Spragens Jeffrey G |
President and CEO |
|
2012-10-25 |
4 |
OE |
$0.25 |
$5,035 |
D/D |
20,138 |
2,145,285 |
|
- |
|
Frost Phillip Md Et Al |
10% Owner |
|
2012-10-25 |
4 |
OE |
$0.25 |
$196,346 |
I/I |
785,383 |
785,383 |
|
- |
|
Rubin Steven D |
Director |
|
2012-10-25 |
4 |
OE |
$0.25 |
$196,346 |
I/I |
785,383 |
785,383 |
|
- |
|
Frost Gamma Investment Trust |
10% Owner |
|
2012-02-17 |
4 |
B |
$0.40 |
$1,800,000 |
I/I |
4,500,000 |
10,478,735 |
1.5 |
- |
|
Hsiao Jane Ph D |
Chairman of the Board |
|
2012-02-17 |
4 |
B |
$0.40 |
$1,800,000 |
D/D |
4,500,000 |
7,303,965 |
3.92 |
- |
|
Pfenniger Richard C Jr |
Director |
|
2012-02-17 |
4 |
B |
$0.40 |
$50,000 |
D/D |
125,000 |
240,000 |
2.39 |
- |
|
Spragens Jeffrey G |
President and CEO |
|
2011-04-05 |
4 |
B |
$1.03 |
$14,578 |
D/D |
12,500 |
1,875,147 |
3.15 |
- |
|
Spragens Jeffrey G |
President and CEO |
|
2010-10-01 |
4 |
B |
$2.00 |
$4,000 |
D/D |
2,000 |
1,862,647 |
3.15 |
- |
|
Filipi Charles |
Chief Medical Officer |
|
2010-09-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
700,000 |
700,000 |
|
- |
|
Filipi Charles |
Chief Medical Officer |
|
2010-09-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
700,000 |
707,046 |
|
- |
|
Spragens Jeffrey G |
President and CEO |
|
2010-09-23 |
4 |
B |
$1.98 |
$1,985 |
D/D |
1,000 |
1,860,647 |
3.15 |
- |
|
Spragens Jeffrey G |
President and CEO |
|
2010-09-22 |
4 |
B |
$2.09 |
$2,095 |
D/D |
1,000 |
1,859,647 |
3.15 |
- |
|
Spragens Jeffrey G |
President and CEO |
|
2010-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
17,042 |
1,858,647 |
|
- |
|
Spragens Jeffrey G |
President and CEO |
|
2010-09-10 |
4 |
OE |
$1.00 |
$106,638 |
D/D |
106,638 |
1,841,605 |
|
- |
|
Hsiao Jane Ph D |
Chairman of the Board |
|
2010-09-10 |
4 |
A |
$0.00 |
$0 |
I/I |
76,261 |
1,913,470 |
|
- |
|
Hsiao Jane Ph D |
Chairman of the Board |
|
2010-09-10 |
4 |
OE |
$1.00 |
$477,209 |
I/I |
477,209 |
1,837,209 |
|
- |
|
Frost Gamma Investment Trust |
10% Owner |
|
2010-09-10 |
4 |
A |
$0.00 |
$0 |
I/I |
76,261 |
5,978,735 |
|
- |
|
Frost Gamma Investment Trust |
10% Owner |
|
2010-09-10 |
4 |
OE |
$1.00 |
$477,209 |
I/I |
477,209 |
5,902,474 |
|
- |
|
Davis Stewart B |
COO |
|
2010-06-22 |
4 |
B |
$1.60 |
$1,600 |
I/I |
1,000 |
1,000 |
1.91 |
- |
|
Frost Gamma Investment Trust |
10% Owner |
|
2010-06-22 |
4 |
B |
$1.50 |
$7,500 |
I/I |
5,000 |
5,425,265 |
1.5 |
- |
|
Frost Gamma Investment Trust |
10% Owner |
|
2010-06-21 |
4 |
B |
$1.36 |
$6,964 |
I/I |
5,000 |
5,420,265 |
1.5 |
- |
|
Frost Gamma Investment Trust |
10% Owner |
|
2010-06-15 |
4 |
B |
$1.00 |
$1,300,000 |
I/I |
1,300,000 |
5,415,265 |
1.5 |
- |
|
293 Records found
|
|
Page 10 of 12 |
|
|